Document is current
Any future updates will be listed below
-
Authors
Langenbach, Isabel L. https://orcid.org/0000-0001-7410-0635
Langenbach, Marcel C.
Mayrhofer, Thomas
Foldyna, Borek
Maintz, David
Klein, Konstantin
Wienemann, Hendrik
Krug, Kathrin B.
Hellmich, Martin
Adam, Matti
Naehle, Claas P.
-
Funding
Funding for this research was provided by:
Universitätsklinikum Köln
- License Information
-
More Information
Article History
Received: 16 July 2023
Revised: 25 August 2023
Accepted: 17 September 2023
First Online: 18 November 2023
Declarations
:
: The scientific guarantor of this publication is Marcel C. Langenbach, MD.
: The authors declare that the research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.The authors of this manuscript declare relationships with the following companies:Hendrik Wienemann has received institutional grant support from Abbott Vascular.Borek Foldyna has received unrelated research grants from the NHI/NHLBI, AstraZeneca, Eli Lilly, and MedTrace.All other authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: Thomas Mayrhofer and Martin Hellmich kindly provided statistical advice for the manuscript.
: Written informed consent was obtained from all patients in this study.
: Institutional Review Board approval was obtained. The HIPAA-compliant study protocol was approved by the local institutional review board (IRB) (IRB No. 21-1245, German clinical trials register DRKS00025702) as a quality assurance trial. Written informed consent was obtained before inclusion. Patients were consecutively enrolled for this prospective study between June 2021 and November 2021.
: No study subjects have been previously reported.
: • prospective• experimental Study• performed at one institution
